Hims & Hers Health Inc (NYSE:HIMS) shares traded 6.25% higher at $55.21 on Wall Street last session.
HIMS stock price is now 62.20% away from the 50-day moving average and 98.09% away from the 200-day moving average. The market capitalization of the company currently stands at $12.36B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target maintained at $30, TD Cowen recently Downgraded its rating from Buy to Hold for Hims & Hers Health Inc (NYSE: HIMS). On February 18, 2025, Morgan Stanley Downgraded its previous ‘Overweight’ rating to ‘Equal-Weight’ on the stock increasing its target price from $42 to quote $60, while ‘Citigroup’ rates the stock as ‘Sell’
In other news, Melissa Baird, Officer bought 33,333 shares of the company’s stock on May 12 ’25. The stock was bought for $1,840,315 at an average price of $55.21. An SEC document containing details of the transaction can be found on the SEC’s website. On May 12 ’25, Officer Boughton Soleil bought 3,235 shares of the business’s stock. A total of $181,160 was incurred on buying the stock at an average price of $56.00. A total of 18.02% of the company’s stock is owned by insiders.
During the past 12 months, Hims & Hers Health Inc has had a low of $12.07 and a high of $72.98. As of last week, the company has a debt-to-equity ratio of 0.12, a current ratio of 1.59, and a quick ratio of 1.32.
The net profit margin was 9.21% and return on equity was 36.79% for HIMS. The company reported revenue of $586.01 million for the quarter, compared to $278.17 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 110.67 percent.
